Consistently, GGTI-DU40, but not SN-DU40, enhanced TRAIL's effect on decreasing the survival of NSCLC cells in a concentration-dependent manner (Fig. 4C). The gene discussed is PGGT1B; the disease is non-small cell lung carcinoma.